Loading clinical trials...
Loading clinical trials...
Non-inferiority Study of a New Therapeutic Strategy for Gout: Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration - FEFACRIGOU Trial
Conditions
Interventions
Adenuric
Locations
6
France
CHU de Caen
Caen, France
Centre Hospitalier Public du Cotentin
Cherbourg, France
CHG Dieppe
Dieppe, France
CHI Elbeuf, Louvier, Val de Reuil
Elbeuf, France
GH Le Havre
Le Havre, France
CHU de Rouen
Rouen, France
Start Date
August 2, 2023
Primary Completion Date
January 1, 2027
Completion Date
January 1, 2027
Last Updated
January 22, 2026
NCT07453004
NCT07504146
NCT07089875
NCT07116746
NCT07295496
NCT03047369
Lead Sponsor
University Hospital, Rouen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions